๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Leptomeningeal dissemination of primary central nervous system tumors of childhood

โœ Scribed by Dr. Roger J. Packer; Kathy R. Siegel; Leslie N. Sutton; Phillip Litmann; Derek A. Bruce; Luis Schut

Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
487 KB
Volume
18
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II evaluation of topotecan for ped
Phase II evaluation of topotecan for pediatric central nervous system tumors
โœ Susan M. Blaney; Peter C. Phillips; Roger J. Packer; Richard L. Heideman; Stacey ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 473 KB ๐Ÿ‘ 2 views

## BACKGROUND. Topotecan is a topoisomerase I inhibitor that has good penetration across the blood-brain barrier and significant antitumor activity against human brain tumor xenografts. In a Phase I trial in children with refractory cancer, topotecan was well tolerated when administered as a 24-ho

Primary central nervous system lymphoma:
Primary central nervous system lymphoma: a clinicopathological study of 28 cases
โœ H. Pels; M. Deckert-Schlรผter; A. Glasmacher; R. Kleinschmidt; R. Oehring; H.-P. ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 291 KB ๐Ÿ‘ 2 views

A group of 28 consecutive patients (mean age 59 years) with primary central nervous system lymphoma (PCNSL) was treated with different regimens, including steroids only, radiotherapy (RT), chemotherapy or combinations of all. Lymphoma was classiยฎed as high grade malignant B-cell non-Hodgkin's lympho